Sugammadex Dosage Based on Ideal Body Weight for Profound Rocuronium-induced Neuromuscular Blockade Reversal in Morbidly Obese Patients
Clinical trial NCT02545595 · COMPLETED
Trial details
- NCT number
- NCT02545595
- Sponsor
- Poitiers University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2013-12-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.